Innoviva (INVA) insider buying

Healthcare · Biotechnology · Market cap $1.5B

5 open-market purchases of INVA by Innoviva's executives and directors since May 2023, worth $7M in total, from SEC Form 4 filings.

The most recent: Alexander J Denner bought $91,280 on June 5, 2023.

The biggest buyer over the period is Alexander J Denner: 5 purchases, $7M.

By year

YearPurchasesValue
20235$7M

Biggest buyers

InsiderBuysValue
Alexander J Denner
5$7M

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Jun 5, 2023 Alexander J Denner
7,000$13.04$91,280 Form 4
May 30, 2023 Alexander J Denner
120,000$13.01$2M Form 4
May 25, 2023 Alexander J Denner
50,000$13.09$654,500 Form 4
May 17, 2023 Alexander J Denner
50,000$13.07$653,500 Form 4
May 11, 2023 Alexander J Denner
290,000$12.34$4M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for INVA.
Open INVA in Investingly

Questions

Are Innoviva insiders buying the stock?

5 open-market purchases of INVA by Innoviva's executives and directors since May 2023, worth $7M in total, from SEC Form 4 filings. The most recent: Alexander J Denner bought $91,280 on June 5, 2023.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Innoviva's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.